New York State Contract Reporter #SQ26-019

Stony Brook University Hospital Seeks QALSODY (Tofersen) 100mg/15ml SDV from Biogen

Stony Brook University Hospital, part of the State University of New York (SUNY) system, is seeking to procure a specialized pharmaceutical product for patient care: - Government Buyer: - State University of New York (SUNY), SUNY Stony Brook University Hospital, Hospital Purchasing Office - Contact: Robert Meyn, Sr Procurement Officer - OEM and Vendor Details: - Original Equipment Manufacturer (OEM): Biogen - Distributor: Priority Health Care/Curascript - Products Requested: - QALSODY (Tofersen) 100mg/15ml SDV - Part number: QALSODY (Tofersen) 100mg/15ml SDV - Quantity: Not specified - Description: Pharmaceutical product for medical use - Notable Requirements: - Procurement is discretionary under NYS Education Law 355(5)(A) - Estimated contract value up to $125,000 - One-year contract term - Strict compliance with New York State Finance Law §139 j&k (Lobbying Law) and vendor responsibility requirements - No set-aside goals for SDVOB, MWBE, or DBE - No sealed bid; interested vendors must contact the designated campus contact within the specified period

Description

Stony Brook University Hospital intends to purchase QALSODY (TORFERSEN) 100mg/15ml SDV manufactured by BIOGEN and distributed through Priority Health Care/ Curascript under its discretionary authority pursuant to NYS Education Law §355(5)(A). The contract term is one year, and the procurement is for medical and health care commodities with an estimated value up to $125,000. No sealed bid will be held, and interested vendors must contact the designated campus contact within 15 business days of the notice. The procurement is subject to NYS Finance Law §139 j&k (Lobbying Law), and the successful contractor must comply with vendor responsibility and other state requirements.

View original listing